Andrew Ross, Author at Born2Invest

Andrew Ross

Andrew Ross is a features writer whose stories are centered on emerging economies and fast-growing companies. His articles often look at trade policies and practices, geopolitics, mining and commodities, as well as the exciting world of technology. He also covers industries that have piqued the interest of the stock market, such as cryptocurrency and cannabis. He is a certified gadget enthusiast.

Born2Invest uses cookies in order to improve your experience and make further customizations to how we present our content. By continuing to use our website, you accept and give your consent to our practices as described in the following: our revised Privacy Policy, Cookie Policy, and Terms of Use.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Born2Invest

Andrew Ross

Stories By Andrew Ross

Mali and the EIB sign $10.8 billion loan agreement

Burkina Faso to host event to promote cloud computing

Argentina opens new spaces for testing cannabis oils

Facebook Africa presents its ambitions for Francophone Africa in 2020

ACS BIOTECH is relaunching a crowdfunding campaign for a human clinical trial

UK seeks new business partners in Africa

Mexican Senate set to debate cannabis regulation

Why individualized cancer therapy will revolutionize oncology

Qiagen stock collapses after take-over talks fall apart

European biotech firm BioNTech to create individualized cancer treatments